High Outlier
Strength
4 mg/.5mL
Manufacturer
GlaxoSmithKline LLCNDC
00173073900
Classification
Brand
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Last Updated
4/22/2026
Active Ingredients
SUMATRIPTAN SUCCINATEApproval Type
New Drug (NDA)
FDA Application
NDA020080On Market Since
4/6/2006
Pharmacological Classes
Serotonin 1b Receptor Agonists
Serotonin 1d Receptor Agonists
Serotonin-1b and Serotonin-1d Receptor Agonist
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
MAXALT MLT 10 MG TABLET
Brand
78206014301•Organon LLC
$44.3130
per EA
MAXALT 10 MG TABLET
Brand
78206014201•Organon LLC
$44.4765
per EA
RELPAX 40 MG TABLET
Brand
00049234005•Roerig
$77.1492
per EA
RELPAX 40 MG TABLET
Brand
58151036856•Viatris Specialty LLC
$77.1492
per EA
RELPAX 40 MG TABLET
Brand
58151036896•Viatris Specialty LLC
$77.1492
per EA
RELPAX 20 MG TABLET
Brand
00049233045•Roerig
$77.3165
per EA
RELPAX 20 MG TABLET
Brand
58151036756•Viatris Specialty LLC
$77.3165
per EA
TOSYMRA 10 MG NASAL SPRAY
Brand
70792081261•Tonix Medicines, Inc.
$108.1537
per EA
ZOMIG 2.5 MG NASAL SPRAY
Brand
64896008312•Amneal Pharmaceuticals LLC
$108.5647
per EA
ZOMIG 5 MG NASAL SPRAY
Brand
64896008412•Amneal Pharmaceuticals LLC
$109.5042
per EA